Tirzepatide, a dual GIP/GLP-1 agonist available as compounded injection ($289/mo) or oral tablet ($349/mo), engages a different pathway that some IBD patients tolerate betterthough individual responses vary
Nausea is the most common, particularly when starting treatment or increasing doses
Both use the same oil-based preparations such as testosterone cypionate or enanthate
The ingredients in supplements, including vitamins, minerals, herbs, and other botanicals, can have unintended negative consequences when combined with some medications, other supplements, foods, and alcohol ( For example, vitamin E supplements may increase the risk of bleeding in those on blood-thinning medications, while calcium supplements may limit the effectiveness of antibiotics and reduce the absorption of iron from foods and supplements ( Some supplements may also affect the accuracy of lab results
Drevon CA
Key Facts About Tirzepatide: Mechanism: Dual-action (targets both GLP-1 and GIP receptors)